Asian J Androl. 2018 May-Jun; 20(3): 244–252.
Published online 2018 Apr 13. doi: 10.4103/aja.aja_14_18
PMCID: PMC5952478
PMID: 29667615
Vitamin D in prostate cancer
Donald L Trump and Jeanny B Aragon-Ching
Author information Article notes Copyright and License information Disclaimer
Go to:
Abstract
Signaling through the vitamin D receptor has been shown to be biologically active and important in a number of preclinical studies in prostate and other cancers. Epidemiologic data also indicate that vitamin D signaling may be important in the cause and prognosis of prostate and other cancers. These data indicate that perturbation of vitamin D signaling may be a target for the prevention and treatment of prostate cancer. Large studies of vitamin D supplementation will be required to determine whether these observations can be translated into prevention strategies. This paper reviews the available data in the use of vitamin D compounds in the treatment of prostate cancer. Clinical data are limited which support the use of vitamin D compounds in the management of men with prostate cancer. However, clinical trials guided by existing preclinical data are limited.